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Abstract
Eight patients with the middle aortic syndrome are described. They were aged 2 months to 14 years at diagnosis; follow up was one to 11 years. Clinical presentations included asymptomatic hypertension (n=5), severe headache, nose bleed, and chest pain (n= 1), and cardiac failure (n= 1). All had severe hypertension requiring multiple drug treatment. Diminished peripheral pulses were not helpful in the diagnosis, which is made on aortography. Associated clinical findings were Williams' syndrome (n=3) and appreciable eosinophilia (n=3). The differential diagnosis includes Takayasu's arteritis, fibromuscular dysplasia, and neurofibromatosis. Blood pressure was adequately controlled by medical treatment in six patients. Surgical angioplasty was performed in two. One patient remained nornotensive without drg treatment 21 months after operation; the other died of sepsis and uncontrollable haemorrhage in the postoperative period. Medical treatment is satisfactory in most cases: surgery should be reserved for those in whom blood pressure cannot be controlled without unacceptable side effects of drug treatment. Although rare, the middle aortic syndrome should be considered in the differential diagnosis of hypertension when commoner causes have been excluded. Aortography is necessary for diagnosis.
The middle aortic syndrome (MAS) is an uncommon condition and is characterised by severe narrowing of the abdominal aorta with involvement of the renal and visceral branches. It was first described by Sen et Nevertheless, it is worthwhile attempting to make the distinction as anti-inflammatory drugs may be useful in some patients with Takayasu's disease. The latter condition occurs primarily in young women with associated rheumatic complaints including arthritis, myalgia, pleuritis, pericarditis, fever and rash, none of which was present in any of our patients. The ESR is usually raised. A mixed type of segmental involvement of arteries is often present and the disease is very uncommon in non-oriental populations.2 15 16 An arteriopathy very similar to that of MAS has recently been described in mucopolysaccharidoses 1 H (Hurler's syndrome) and 1 S (Scheie's syndrome). Co-trimoxazole and life in the raw No matter how hard their lives may seem people have, in the words of Peter Medawar, 'a very decided preference" in favour of life for themselves and those they love. In the Jumla district of western Nepal life, it seems, is about as tough as it can get. It is a mountainous district with about 80 000 people living at a height of 8 or 9000 feet in a cold, dry climate with no roads, poor housing, low literacy, inadequate food, no routine child health services, and nearly 20% of children dying in infancy. Nevertheless, despite an endemic fatalism about child deaths, one of the striking findings of a recent study (Mrigendra Raj Pandey and colleagues, Lancet 1991;338:993-7) was that mothers quickly learned to recognise pneumonia and bring their children for treatment.
For every 1000 people one was chosen to be the community health worker and that person was given nine days training, the aim being to teach them to recognise pneumonia in children under the age of 5 years and to treat it with a five day course of cotrimoxazole. The health workers travelled around their villages visiting families with young children every two weeks and actively seeking out cases of pneumonia diagnosed on the basis of tachypnoea and chest indrawing. In the first year of the study only 15% of cases were actively referred by the parents to the health worker but by the third year the proportion was 56%. Pneumonia and diarrhoea accounted for over 60% of deaths in children less than 5 years old with pneumonia predominating under 6 months and diarrhoea after that.
The study lasted for three years and during that time the overall relative risk of death from all causes compared with that before the introduction of the treatment scheme fell from 0-87 (95% confidence interval 0-73 to 1 03) in the first year to 0-72 (0-63 to 0-82) in the third. The relative risk of death from pneumonia was 0-88 (0-59 to 1-32) in the first year of the study and 0 70 (0 50 to 0-97) in the third and from diarrhoea it was 0-81 (0-62 to 1 07) in the first year and 0-64 (0-52 to 0-77) in the third. The health workers were given no training in the treatment of diarrhoea and the improvement in diarrhoeal death rate was attributed to better overall health and nutrition of the children consequent upon the treatment of pneumonia. By far the greatest reduction in mortality was in the second six months of life. In that age group the relative risk of death from all causes was 0-68 (0 43 to 1-08) in the first year of the study and 0-36 (0-24 to 0-55) in the third. In children between 1 and 5 years the effect was relatively disappointing (relative risk 1-02 (0-76 to 1-37) in year 1 and 0-89 (0 73 to 1-09) in year 3).
This study shows that uneducated local people can be taught to recognise and treat pneumonia in young children with a subsequent fall in infant mortality and the financial cost was small (less than US$4 per child per year). Mothers soon learn to suspect pneumonia and respond to the provision of a service. Presumably the next step will be to teach them how to manage diarrhoea.
